Precision in Practice: A Functional Medicine Workshop (Overview)

Overview

Be part of the conversation shaping the future of cancer care at Precision in Practice: A Functional Medicine Workshop on July 1 and 2, 2026! This hybrid event—offered both in person at the National Cancer Institute (NCI) Shady Grove Campus in Rockville, MD, and online—will bring together leaders from academia, industry, government, and patient advocacy to explore the evolving landscape of functional precision medicine.

This workshop is designed to spark collaboration and help move functional precision oncology more quickly from the lab into clinical practice. Attendees will learn about the current landscape of the field and define critical scientific questions that will shape progress over the next decade.

To facilitate these objectives, the workshop is organized into two thematic days:

  • Day 1: The State-of-the-Art in Functional Precision Medicine
    This day will provide a comprehensive overview of current technologies, applications, and successes to date in using functional assays to guide cancer therapy.
  • Day 2: Charting the Course—Scientific Questions for the Future of Cancer Care
    The second day will shift to interactive sessions focused on identifying and prioritizing key challenges and unanswered scientific questions that will define the future direction of the field.

Explore the draft agenda and register today!

Date and Time

  • Wednesday, July 1, 2026, from 9:00 a.m.–5:00 p.m. ET
  • Thursday, July 2, 2026, from 9:00 a.m.–5:00 p.m. ET

Venue

NCI Shady Grove
Joseph F. Fraumeni Conference Room (TE-406/408/410)
9609 Medical Center Drive
Rockville, MD 20850

Learn about the venue.

Registration Deadline

Registration is free and required to attend either in person or online.

  • In-person attendance: Register by May 13, 2026.
  • Virtual attendance: Register by June 29, 2026.

Please note that onsite registration will not be available.

Register now!

Organizing Committee Members

  • James Doroshow, M.D.
    Director of the Division of Cancer Treatment and Diagnosis at NCI
  • Jeffrey Tyner, Ph.D.
    Professor of Medicine at Oregon Health & Science University
  • Keith Flaherty, M.D.
    Director of Clinical Research at Mass General Cancer Center

Questions?

If you have questions about the workshop, please contact Ana Robles at roblesa@mail.nih.gov.